Immunogenicity and Safety of a Bivalent (omicron BA.5 Plus Ancestral) SARS-CoV-2 Recombinant Spike Protein Vaccine As a Heterologous Booster Dose: Interim Analysis of a Phase 3, Non-Inferiority, Randomised, Clinical Trial
LANCET INFECTIOUS DISEASES(2024)
关键词
Vaccines,spike protein
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要